20:40:09 EDT Sat 27 Apr 2024
Enter Symbol
or Name
USA
CA



Supreme Pharmaceuticals Inc (2)
Symbol SL
Shares Issued 76,231,197
Close 2015-07-30 C$ 0.155
Market Cap C$ 11,815,836
Recent Sedar Documents

Supreme Pharmaceuticals closes $684,449 financing

2015-07-30 18:11 ET - News Release

Mr. John Fowler reports

SUPREME COMPLETES PRIVATE PLACEMENT FOR $684,449 AGGREGATE SUBSCRIPTION PROCEEDS

Supreme Pharmaceuticals Inc. has closed a private placement financing for gross proceeds of $684,449.82. Upon closing the financing, Supreme issued 4,026,469 units at a price of 17 cents per unit. Each unit consists of one common share and one common share purchase warrant. Each warrant is exercisable for one common share at a price of 32 cents per share prior to July 27, 2017, subject to an accelerated expiry period upon 30 days of notice by the company to the subscriber, if the common shares trade at or about 60 cents for any five-day period during the term of the warrants.

"I am overwhelmed by the tremendous support Supreme enjoys from the local community," stated John Fowler, president of Supreme. "We were approached by local residents and key contactors who share our vision for the future of the medical marijuana industry and want to be a part of our journey. This type of support has been invaluable for us since day one and will continue to be essential when we are able to move forward into the operating stage of our business."

The company paid total finders' fees of $17,679.99 and issued 103,999 warrants to certain arm's-length parties in the connection with the subscriptions of certain subscribers who participated in the financing. In addition, three employees converted debts as part of the financing. Pursuant to the settlement, the company issued 233,315 common shares at a deemed price of 17 cents per common share to settle debts totalling $39,663.54. The terms of the settlement were unanimously approved by the disinterested members of the company's board of directors. The common shares and warrants issued pursuant to the financing and settlement are subject to a hold period that expires Nov. 30, 2015.

In addition, the company has extended the expiry date of warrants issued in connection to its private placement closed on Sept. 22, 2015, and Oct. 6, 2014. Of the warrants, 4,478,465 warrants issued on Sept. 22, 2014, with an expiry date of Sept. 22, 2015, will now expire Sept. 22, 2016, and 897,000 warrants issued on Oct. 6, 2014, with an expiry date of Oct. 6, 2015, will now expire Oct. 6, 2016.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.